Cargando…

The Effects of Serum from Prostate Cancer Patients with Elevated Body Mass Index on Prostate Cancer Cells In Vitro

We examined whether serum from obese, compared to non-obese, PCa (prostate cancer) patients creates a growth-enhancing tumor micro-environment in vitro. Serum from 80 subjects was divided into four groups: normal weight men with and without PCa and overweight/obese men with and without PCa. Cell pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mora, Benjamin C, Fleshner, Neil E, Klotz, Laurence H, Venkateswaran, Vasundara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404997/ https://www.ncbi.nlm.nih.gov/pubmed/25987846 http://dx.doi.org/10.4137/LPI.S23135

Ejemplares similares

Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, Platelet Factor-4
por: Cervi, David, et al.
Publicado: (2010)

Discovery of Novel Hypermethylated Genes in Prostate Cancer Using Genomic CpG Island Microarrays
por: Kron, Ken, et al.
Publicado: (2009)

Does increased body mass index lead to elevated prostate cancer risk? It depends on waist circumference
por: Choi, Jin Bong, et al.
Publicado: (2020)

Serum Adipokines as Predictors for the Outcome of Prostate Biopsies at Early Stage Prostate Cancer Diagnosis
por: Ahmad, Ardalan E, et al.
Publicado: (2019)

Diet, Obesity, and Cancer Progression: Are Adipocytes the Link?
por: Toren, Paul, et al.
Publicado: (2013)

Childhood body mass index and the risk of prostate cancer in adult men
por: Aarestrup, J, et al.
Publicado: (2014)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
por: Harrison, Sean, et al.
Publicado: (2020)

Active surveillance for low-risk prostate cancer
por: Klotz, Laurence
Publicado: (2012)

Oral contraceptive use is associated with prostate cancer: an ecological study
por: Margel, David, et al.
Publicado: (2011)

Statin Use and Survival Among Men Receiving Androgen-Ablative Therapies for Advanced Prostate Cancer: A Systematic Review and Meta-analysis
por: Jayalath, Viranda H., et al.
Publicado: (2022)

Prostate cancer gene expression signature of patients with high body mass index
por: Sharad, Shashwat, et al.
Publicado: (2010)

Variability of body mass index and risks of prostate, lung, colon, and ovarian cancers
por: Sun, Yangyang, et al.
Publicado: (2022)

Contemporary approach to active surveillance for favorable risk prostate cancer
por: Klotz, Laurence
Publicado: (2019)

Prognostic Value of Body Mass Index in Korean Patients with Castration-Resistant Prostate Cancer
por: Park, Jeong Min, et al.
Publicado: (2012)

Body mass index trajectories and prostate cancer risk: Results from the EPICAP study
por: Lavalette, Céline, et al.
Publicado: (2020)

Associations between Body Mass Index and Prostate Cancer: The Impact on Progression-Free Survival
por: Popovici, Dorel, et al.
Publicado: (2023)

The impact of body mass index on prostate cancer: An updated systematic review and meta-analysis
por: Tzenios, Nikolaos, et al.
Publicado: (2022)

Active Surveillance for Intermediate Risk Prostate Cancer
por: Dall'Era, Marc A., et al.
Publicado: (2016)

Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia
por: Kiebish, Michael A., et al.
Publicado: (2021)

Active surveillance and focal therapy for low-intermediate risk prostate cancer
por: Klotz, Laurence
Publicado: (2015)

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
por: Andreas, Darian, et al.
Publicado: (2016)

Clinical Significance of Serum Adipokines according to Body Mass Index in Patients with Clinically Localized Prostate Cancer Undergoing Radical Prostatectomy
por: Kang, Minyong, et al.
Publicado: (2018)

Association between body mass index and localized prostate cancer management and disease‐specific quality of life
por: Samora, Nathan L., et al.
Publicado: (2022)

Serum biomarkers of inflammation for diagnosis of prostate cancer in patients with nonspecific elevations of serum prostate specific antigen levels
por: Santotoribio, Jose D., et al.
Publicado: (2019)

The Relationship Between Metformin and Serum Prostate‐Specific Antigen Levels
por: Jayalath, Viranda H., et al.
Publicado: (2016)

A narrative review of pelvic lymph node dissection in prostate cancer
por: Cheung, Douglas C., et al.
Publicado: (2020)

Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
por: Clark, Roderick, et al.
Publicado: (2022)

SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
por: Azzato, Elizabeth M, et al.
Publicado: (2009)

Effect of Body mass index on the performance characteristics of PSA-related markers to detect prostate cancer
por: Zhu, Yao, et al.
Publicado: (2016)

The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer
por: Yamoah, Kosj, et al.
Publicado: (2016)

Impact of Body Mass Index on Oncological Outcomes of Prostate Cancer Patients after Radical Prostatectomy
por: Yu, Young Dong, et al.
Publicado: (2018)

Correlation between Body Mass Index and Gleason Score in Men with Prostate Cancer in Southeastern Nigeria
por: Nwadi, Uchenna Victor, et al.
Publicado: (2021)

Active Surveillance for Favorable-Risk Prostate Cancer: A Short Review
por: Lawrentschuk, Nathan, et al.
Publicado: (2010)

The ‘C’ Words: parallels and analogies between Prostate Cancer and Covid-19
por: Klotz, Laurence, et al.
Publicado: (2021)

Correlation between body mass index and prostate volume in benign prostatic hyperplasia patients undergoing holmium enucleation of the prostate surgery
por: Batai, Ken, et al.
Publicado: (2021)

Body mass index in relation to prostate-specific antigen-related parameters
por: Lin, Dandan, et al.
Publicado: (2021)

Stereotactic Body Radiotherapy for Prostate Cancer
por: Parikh, Neil R., et al.
Publicado: (2020)

Higher Body Mass Index Increases the Risk for Biopsy-Mediated Detection of Prostate Cancer in Chinese Men
por: Hu, Meng-Bo, et al.
Publicado: (2015)

Association of body mass index and height with risk of prostate cancer among middle-aged Japanese men
por: Kurahashi, N, et al.
Publicado: (2006)

Height, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men
por: Engeland, A, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_dlo1en7ncomg1vvg51ae10rde7